0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and China Seasonal Influenza Vaccines Therapeutics Market Size, Status and Forecast 2021-2027
Published Date: September 2021
|
Report Code: QYRE-Auto-23O3163
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global and China Seasonal Influenza Vaccines Therapeutics Market Size Status and Forecast 2021 2027

Global and China Seasonal Influenza Vaccines Therapeutics Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-23O3163
Report
September 2021
107 Pages
QYResearch
Region: Global, United States, Southeast Asia, North America, Europe, Canada, France, Germany, Italy, Russia, Saudi Arabia, South Korea, Turkey, UAE,
Description
Table of Content
Tables & Figures
Global Seasonal Influenza Vaccines Therapeutics Scope and Market Size
Seasonal Influenza Vaccines Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Influenza Vaccines Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Paediatrics
Adolescence
Adults
Elderly

Segment by Application

Hospitals
Clinics
Others

BY REGION

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Hualan Biological Engineering
Sinovac Biotech
Changchun Institute of Biological Products Co., Ltd.
Shanghai Institute of Biological Products Co., Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Paediatrics
1.2.3 Adolescence
1.2.4 Adults
1.2.5 Elderly
1.3 Market by Application
1.3.1 Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Seasonal Influenza Vaccines Therapeutics Market Perspective (2016-2027)
2.2 Seasonal Influenza Vaccines Therapeutics Growth Trends by Regions
2.2.1 Seasonal Influenza Vaccines Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Seasonal Influenza Vaccines Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Seasonal Influenza Vaccines Therapeutics Industry Dynamic
2.3.1 Seasonal Influenza Vaccines Therapeutics Market Trends
2.3.2 Seasonal Influenza Vaccines Therapeutics Market Drivers
2.3.3 Seasonal Influenza Vaccines Therapeutics Market Challenges
2.3.4 Seasonal Influenza Vaccines Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue
3.1.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Seasonal Influenza Vaccines Therapeutics Revenue
3.4 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio
3.4.1 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Therapeutics Revenue in 2020
3.5 Seasonal Influenza Vaccines Therapeutics Key Players Head office and Area Served
3.6 Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
3.7 Date of Enter into Seasonal Influenza Vaccines Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Type
4.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2022-2027)
5 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Application
5.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
6.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type
6.2.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application
6.3.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
6.4 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country
6.4.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
7.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type
7.2.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application
7.3.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
7.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country
7.4.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type
8.2.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application
8.3.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region
8.4.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
9.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type
9.2.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application
9.3.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country
9.4.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type
10.2.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application
10.3.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country
10.4.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Seasonal Influenza Vaccines Therapeutics Introduction
11.1.4 GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Introduction
11.2.4 Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 CSL
11.3.1 CSL Company Details
11.3.2 CSL Business Overview
11.3.3 CSL Seasonal Influenza Vaccines Therapeutics Introduction
11.3.4 CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.3.5 CSL Recent Development
11.4 MedImmune
11.4.1 MedImmune Company Details
11.4.2 MedImmune Business Overview
11.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Introduction
11.4.4 MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.4.5 MedImmune Recent Development
11.5 Sanofi-Pasteur
11.5.1 Sanofi-Pasteur Company Details
11.5.2 Sanofi-Pasteur Business Overview
11.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Introduction
11.5.4 Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.5.5 Sanofi-Pasteur Recent Development
11.6 Solvay
11.6.1 Solvay Company Details
11.6.2 Solvay Business Overview
11.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Introduction
11.6.4 Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.6.5 Solvay Recent Development
11.7 Hualan Biological Engineering
11.7.1 Hualan Biological Engineering Company Details
11.7.2 Hualan Biological Engineering Business Overview
11.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Introduction
11.7.4 Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.7.5 Hualan Biological Engineering Recent Development
11.8 Sinovac Biotech
11.8.1 Sinovac Biotech Company Details
11.8.2 Sinovac Biotech Business Overview
11.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Introduction
11.8.4 Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.8.5 Sinovac Biotech Recent Development
11.9 Changchun Institute of Biological Products Co., Ltd.
11.9.1 Changchun Institute of Biological Products Co., Ltd. Company Details
11.9.2 Changchun Institute of Biological Products Co., Ltd. Business Overview
11.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction
11.9.4 Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Development
11.10 Shanghai Institute of Biological Products Co., Ltd.
11.10.1 Shanghai Institute of Biological Products Co., Ltd. Company Details
11.10.2 Shanghai Institute of Biological Products Co., Ltd. Business Overview
11.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction
11.10.4 Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Paediatrics
    Table 3. Key Players of Adolescence
    Table 4. Key Players of Adults
    Table 5. Key Players of Elderly
    Table 6. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Seasonal Influenza Vaccines Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Seasonal Influenza Vaccines Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2016-2021)
    Table 10. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2022-2027)
    Table 12. Seasonal Influenza Vaccines Therapeutics Market Trends
    Table 13. Seasonal Influenza Vaccines Therapeutics Market Drivers
    Table 14. Seasonal Influenza Vaccines Therapeutics Market Challenges
    Table 15. Seasonal Influenza Vaccines Therapeutics Market Restraints
    Table 16. Global Seasonal Influenza Vaccines Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players (2016-2021)
    Table 18. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2020)
    Table 19. Ranking of Global Top Seasonal Influenza Vaccines Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
    Table 23. Date of Enter into Seasonal Influenza Vaccines Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2016-2021)
    Table 27. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Seasonal Influenza Vaccines Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2016-2021)
    Table 31. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
    Table 63. GSK Company Details
    Table 64. GSK Business Overview
    Table 65. GSK Seasonal Influenza Vaccines Therapeutics Product
    Table 66. GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
    Table 67. GSK Recent Development
    Table 68. Novartis Company Details
    Table 69. Novartis Business Overview
    Table 70. Novartis Seasonal Influenza Vaccines Therapeutics Product
    Table 71. Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
    Table 72. Novartis Recent Development
    Table 73. CSL Company Details
    Table 74. CSL Business Overview
    Table 75. CSL Seasonal Influenza Vaccines Therapeutics Product
    Table 76. CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
    Table 77. CSL Recent Development
    Table 78. MedImmune Company Details
    Table 79. MedImmune Business Overview
    Table 80. MedImmune Seasonal Influenza Vaccines Therapeutics Product
    Table 81. MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
    Table 82. MedImmune Recent Development
    Table 83. Sanofi-Pasteur Company Details
    Table 84. Sanofi-Pasteur Business Overview
    Table 85. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product
    Table 86. Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
    Table 87. Sanofi-Pasteur Recent Development
    Table 88. Solvay Company Details
    Table 89. Solvay Business Overview
    Table 90. Solvay Seasonal Influenza Vaccines Therapeutics Product
    Table 91. Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
    Table 92. Solvay Recent Development
    Table 93. Hualan Biological Engineering Company Details
    Table 94. Hualan Biological Engineering Business Overview
    Table 95. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product
    Table 96. Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
    Table 97. Hualan Biological Engineering Recent Development
    Table 98. Sinovac Biotech Company Details
    Table 99. Sinovac Biotech Business Overview
    Table 100. Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
    Table 101. Sinovac Biotech Recent Development
    Table 102. Changchun Institute of Biological Products Co., Ltd. Company Details
    Table 103. Changchun Institute of Biological Products Co., Ltd. Business Overview
    Table 104. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product
    Table 105. Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
    Table 106. Changchun Institute of Biological Products Co., Ltd. Recent Development
    Table 107. Shanghai Institute of Biological Products Co., Ltd. Company Details
    Table 108. Shanghai Institute of Biological Products Co., Ltd. Business Overview
    Table 109. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product
    Table 110. Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
    Table 111. Shanghai Institute of Biological Products Co., Ltd. Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Seasonal Influenza Vaccines Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Paediatrics Features
    Figure 3. Adolescence Features
    Figure 4. Adults Features
    Figure 5. Elderly Features
    Figure 6. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Seasonal Influenza Vaccines Therapeutics Report Years Considered
    Figure 11. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 14. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2022-2027)
    Figure 15. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players in 2020
    Figure 16. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue in 2020
    Figure 18. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 19. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 20. North America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
    Figure 22. North America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
    Figure 23. North America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
    Figure 24. United States Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
    Figure 28. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
    Figure 29. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
    Figure 30. Germany Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Region (2016-2027)
    Figure 40. China Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
    Figure 48. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
    Figure 49. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
    Figure 50. Mexico Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
    Figure 56. Turkey Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. GSK Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
    Figure 60. Novartis Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
    Figure 61. CSL Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
    Figure 62. MedImmune Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
    Figure 63. Sanofi-Pasteur Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
    Figure 64. Solvay Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
    Figure 65. Hualan Biological Engineering Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
    Figure 66. Sinovac Biotech Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
    Figure 67. Changchun Institute of Biological Products Co., Ltd. Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
    Figure 68. Shanghai Institute of Biological Products Co., Ltd. Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

China Autogenous Vaccines Market Report Forecast 2021 2027
China Autogenous Vaccines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-22Z1818
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Flu Vaccine market size was US 5154 million and it is expected to reach US 7293.3 million by the end of 2027 with a CAGR of 4.8 during 20212027.Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-11H675
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

120 Pages
Type: Report
Code: QYRE-Auto-34M23
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Sulfachloropyridazine Sodium Market Insights Forecast to 2027
Global and United States Sulfachloropyridazine Sodium Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28M6619
Tue Sep 21 00:00:00 UTC 2021

Add to Cart